The present invention relates to a formulation comprising an anti-OX40 antibody, in particular to a pharmaceutical formulation comprising an antibody specifically binding to an OX40 molecule and/or an antigen-binding fragment thereof, a buffer, a stabilizer, and a surfactant. Furthermore, the invention relates to a use of the formulation for the treatment or prophylaxis of diseases.本發明涉及包含抗OX40抗體的製劑,尤其涉及包含特異性結合OX40分子的抗體和/或抗原結合片段、緩衝劑、穩定劑和表面活性劑的藥物製劑。此外,本發明還涉及這些製劑的疾病治療或預防用途。